Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Monoclonal antibody against h3n2 canine influenza virus ha2 protein

A monoclonal antibody, canine influenza virus technology, applied in the direction of antiviral immunoglobulin, antibody, antiviral agent, etc., can solve the problem of limited neutralization activity of monoclonal antibody, achieve good protection effect, reduce risk, specificity strong effect

Active Publication Date: 2017-08-11
NANJING AGRICULTURAL UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the high variability in the amino acid sequence of HA1, the neutralizing activity of monoclonal antibodies against HA1 is limited [deJong JC, Palache AM, Beyer W, et al. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003, 115:63 -73.]; and HA2 is located in the stem of HA, which is the conserved region of HA of all subtypes of influenza virus, and plays a key role in the adhesion of the virus and the invasion of the host cell membrane

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monoclonal antibody against h3n2 canine influenza virus ha2 protein
  • Monoclonal antibody against h3n2 canine influenza virus ha2 protein
  • Monoclonal antibody against h3n2 canine influenza virus ha2 protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0035] Below in conjunction with specific embodiment. The experimental method that does not indicate specific condition in the embodiment, generally adopts routine condition, for example " Molecular Cloning Laboratory Handbook " (New York: Cold Spring Harbor Laboratory Press, 1989) (Sambrook et al.) described condition, or according to The method recommended by the manufacturer. For standard hybridoma technology, refer to [Vareckova E, Betakova T, Mucha V, et al. Preparation of monoclonal antibodies for the diagnosis of influenza A infection using different immunization protocols. J Immunol Methods 1995, 180: 107-116].

[0036] (1) Preparation of monoclonal antibody to H3N2 canine influenza virus HA2 protein

[0037] 1. Selection of standard strains

[0038] The standard strain used in the present invention is canine influenza virus strain A / Canine / Jiangsu / 06 / 2010 (H3N2) (abbreviated as JS / 10), whose GenBank sequence numbers are from JN247615 to JN247623. The strain and its...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a single clone antibody aiming at H3N2 dog flu virus HA2 protein, belonging to the technical field of biologics. The single clone antibody is prepared by inoculating an H3N2 dog flu virus Jiangsu separated strain JS / 10 separated in 2010 with SPF chicken embryos of 10 days old, collecting allantoic fluid of which the blood clotting titer is greater than or equal to 6, purifying virus inoculation MDCK cells, performing intracutaneous multipoint injection to inoculate mice, after cell fusion, performing three times of ELISA to detect cell supernate that cell colonies are generated, selecting an anti-H3 type hybridization tumor cell strain mAbD7, and recognizing and identifying the antigen so as to verify that the antibody aims at conservative H2A protein, wherein the neutralizing antibody titer is up to 1:12800, and the antibody subclass is IgG2b. The single clone antibody aiming at H3N2 dog flu virus and HA2 protein, which is provided by the invention, provides an important immunological preparation for treating H3N2 dog flu virus infection and has a potential application prospect.

Description

technical field [0001] The invention relates to a monoclonal antibody against H3N2 canine influenza virus HA2 protein, belonging to the field of biotechnology. Standard hybridoma technology, using a H3N2 canine influenza virus strain JS / 10 as the test strain, and finally obtained the monoclonal antibody D7 targeting the conserved protein HA2 through hemagglutination inhibition, neutralization test and Western blotting screening, which is H3N2 canine influenza virus Treatment of infection provides important immune agents. Background technique [0002] The principle of hybridoma technology is to use polyethylene glycol (PEG) as a cell fusion agent to fuse the spleen cells of immunized mice with mouse myeloma cells with long-term reproductive ability in vitro. The effect of HAT selective medium Under this condition, only hybridoma cells that have successfully fused are allowed to grow, and after repeated immunological testing, screening and single cell culture (cloning), a hyb...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/20C07K16/10A61K39/42A61P31/16
Inventor 刘永杰谢星庞茂达林焱赵艳兵梁珊陆承平
Owner NANJING AGRICULTURAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com